Protocol Ledger

NCT03960606 · Phase II · TERMINATED

Study in Adult Asthmatic Patients With Allergic Bronchopulmonary Aspergillosis

Interventional Phase II clinical trial protocol NCT03960606 sponsored by Pulmatrix in Respiratory and Pulmonary, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2019-07-31 Enrollment: 7 participants (ACTUAL) Federal Source: clinicaltrials.gov/study/NCT03960606
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)7 participants (ACTUAL)
Disclosed U.S. Hospital Campuses vs Median (6 sites)3 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT03960606
Protocol FieldVerified Registry Value
NCT IdentifierNCT03960606
Consolidated Lead SponsorPulmatrix
Therapeutic Condition CohortRespiratory and Pulmonary
Clinical Trial PhasePhase II
Overall Recruitment StatusTERMINATED
Registered Enrollment7 participants (ACTUAL)
Registered Start Date2019-07-31
WhyStopped ClassificationFunding / COVID / Operational

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT03960606
Hospital Research SiteLocationSite Profile
National Jewish HealthDenver, COOpen Hospital Dossier ->
Yale Cancer Center and Smilow Cancer HospitalNew Haven, CTOpen Hospital Dossier ->
Montefiore Medical CenterThe Bronx, NYOpen Hospital Dossier ->

Search related sites and sponsors in the Interactive Directory, explore Respiratory and Pulmonary Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI